Acura Pharmaceuticals (ACUR) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:ACUR

0.62
-0.16 (-20.51%)
At close: Feb 22, 2017
0.61
-0.01 (-1.61%)
After Hours: 2/22/2017, 8:10:00 PM

ACUR Key Statistics, Chart & Performance

Key Statistics
Market Cap7.37M
Revenue(TTM)3.38M
Net Income(TTM)N/A
Shares11.88M
Float9.09M
52 Week High3.52
52 Week Low0.5
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.31
PEN/A
Fwd PEN/A
Earnings (Next)05-16
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
ACUR short term performance overview.The bars show the price performance of ACUR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

ACUR long term performance overview.The bars show the price performance of ACUR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ACUR is 0.62 null. In the past month the price increased by 6.9%. In the past year, price decreased by -70.19%.

Acura Pharmaceuticals / ACUR Daily stock chart

ACUR Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ACUR. When comparing the yearly performance of all stocks, ACUR is a bad performer in the overall market: 95.27% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ACUR Financial Highlights

Over the last trailing twelve months ACUR reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS increased by 25.81% compared to the year before.


Industry RankSector Rank
PM (TTM) 100.07%
ROA -41.13%
ROE -356.34%
Debt/Equity 2.52
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)25.81%
Revenue 1Y (TTM)N/A

ACUR Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ACUR Ownership

Ownership
Inst Owners0.01%
Ins Owners478.41%
Short Float %0.07%
Short Ratio0.01

About ACUR

Company Profile

Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.

Company Info

Acura Pharmaceuticals

616 N. NORTH COURT SUITE 120

PALATINE IL 60067

CEO: Robert B. Jones

Phone: 847-705-7709

Acura Pharmaceuticals / ACUR FAQ

What does Acura Pharmaceuticals do?

Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.


What is the current price of ACUR stock?

The current stock price of ACUR is 0.62 null. The price decreased by -20.51% in the last trading session.


What is the dividend status of Acura Pharmaceuticals?

ACUR does not pay a dividend.


What is the ChartMill rating of Acura Pharmaceuticals stock?

ACUR has a ChartMill Technical rating of 2 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.


Where is Acura Pharmaceuticals (ACUR) stock traded?

ACUR stock is listed on the Nasdaq exchange.


Who owns Acura Pharmaceuticals?

You can find the ownership structure of Acura Pharmaceuticals (ACUR) on the Ownership tab.


What is the outstanding short interest for Acura Pharmaceuticals?

The outstanding short interest for Acura Pharmaceuticals (ACUR) is 0.07% of its float.